| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/03/2007 | WO2007049820A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049757A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 05/03/2007 | WO2007049732A1 Method for prevention and/or treatment of rheumatoid arthritis |
| 05/03/2007 | WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007049400A1 Composition for promoting the production of collagen and/or hyaluronic acid |
| 05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | WO2007048787A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 05/03/2007 | WO2007048228A1 Boron-containing compounds, uses and preparation thereof |
| 05/03/2007 | WO2007048186A1 Leukocyte-binding polypeptides and uses thereof |
| 05/03/2007 | WO2007032936A3 Azafused cyclin dependent kinase inhibitors |
| 05/03/2007 | WO2007030939A3 Methods of modulating neurotrophin-mediated activity |
| 05/03/2007 | WO2006081276A8 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099958 Protease inhibitors |
| 05/03/2007 | US20070099932 External preparation for athlete's foot treatment |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099914 Piperidine Derivatives |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099894 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099888 Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid |
| 05/03/2007 | US20070099878 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases |
| 05/03/2007 | US20070099846 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 05/03/2007 | US20070098793 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098792 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098757 E-PTFE foil impregnated with an encapsulated bioactive substance |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | US20070098734 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma, insulin dependent diabetes, arthritis |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | DE19940220B4 Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen A medical preparation for the treatment of osteoarthritis, arthritis and other rheumatic joint diseases |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/03/2007 | CA2627497A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | CA2627211A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 05/03/2007 | CA2625969A1 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
| 05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/02/2007 | EP1780221A1 Anti-synoviolin antibody |
| 05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1779859A2 Use of depsipeptide and congeners thereof as immunosuppressants in preventing or treating rejection following transplantation and for induction of apoptosis of activated CD4 or CD8 T-cells |
| 05/02/2007 | EP1778687A2 Fused ring heterocycle kinase modulators |
| 05/02/2007 | EP1778686A2 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 05/02/2007 | EP1778676A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 05/02/2007 | EP1778671A1 Piperazine derivatives with ccr3 inhibiting activity |
| 05/02/2007 | EP1778653A1 Biaryl heterocyclic compounds and methods of making and using the same |
| 05/02/2007 | EP1778646A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 05/02/2007 | EP1778633A1 Indoles useful in the treatment of inflammation |
| 05/02/2007 | EP1778632A1 Indoles useful in the treatment of inflammation |
| 05/02/2007 | EP1778625A1 Non-glycosidic and non-peptidic select inhibitors, and the use thereof |
| 05/02/2007 | EP1778622A1 Para-alkyl-substituted n-(4-hydroxy-3-methoxy-benzyl) cinnamamides and the use thereof for producing drugs |
| 05/02/2007 | EP1778292A2 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 05/02/2007 | EP1778289A1 Carrier for enteral administration |
| 05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 05/02/2007 | EP1778244A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 05/02/2007 | EP1778241A1 Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor |
| 05/02/2007 | EP1778238A1 Dihydropteridinone infusion solution having a long shelf life |
| 05/02/2007 | EP1778237A1 Use of aminopterin for treating cancer and inflammatory disorders |
| 05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 05/02/2007 | EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
| 05/02/2007 | EP1494692B1 Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis |
| 05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1341542B1 Indanylderivatives for treating airway diseases |
| 05/02/2007 | EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives |
| 05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | CN1957084A Bone marrow-relevant cell participating the maintenance and/or repair of tissue |
| 05/02/2007 | CN1956993A Macrolides with antiinflammatory activity |
| 05/02/2007 | CN1956989A Purine derivative |
| 05/02/2007 | CN1956955A Neurogenic pain control agent composition |
| 05/02/2007 | CN1956721A Quinazolinone derivatives useful as vanilloid antagonists |
| 05/02/2007 | CN1956710A Methods to relief pain |
| 05/02/2007 | CN1955192A Protein for promoting erythrocyte growth factor activity and its use |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1955163A Cyclooxygenase-2 selection inhibitor and its medicine use |
| 05/02/2007 | CN1955151A Alpha-bulnesene, its preparation and its use |
| 05/02/2007 | CN1954810A Preparation method of multi-type superfine naproxen medcine granule |
| 05/02/2007 | CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313159C Hab18G/CD147 molecule small segment interfering RNA medicine and application thereof |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313124C Health medicinal wine for traumatic injury |
| 05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211597 Antiinflammatory agents; rheumatic diseases; anticancer agents |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |